Diversified Healthcare Trust (DHC) Stock Forecast
DHC analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 5 analysts
- Price target
- $10.15 average of analyst targets
- Upside to target
- +33.7% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $0.15
- 52-week range
- $4.10 – $9.64
DHC analyst ratings
5 analystsNumber of analysts at each rating.
DHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
DHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.13 | −$0.13 | −$0.13 | −$0.22 | +42.2% | 1 |
| Current fiscal year (2026) | −$0.63 | −$0.66 | −$0.59 | −$1.19 | +47.1% | 3 |
| Next fiscal year (2027) | −$0.43 | −$0.50 | −$0.37 | −$0.55 | +19.1% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
DHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $368.7M | $365.4M | $373.5M | −5.1% | 4 |
| Current fiscal year (2026) | $1.47B | $1.46B | $1.48B | −4.2% | 4 |
| Next fiscal year (2027) | $1.56B | $1.49B | $1.61B | +6.0% | 5 |
DHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
DHC revenue: reported and forecast
DHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.16 | −$0.15 | −$0.15 | −$0.15 | −$0.13 | −18.8% | 1 up · 0 down |
| Current fiscal year (2026) | −$0.59 | −$0.57 | −$0.60 | −$0.60 | −$0.63 | +7.4% | 1 up · 1 down |
| Next fiscal year (2027) | −$0.47 | −$0.45 | −$0.47 | −$0.47 | −$0.43 | −6.5% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
DHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; DHC beat in 8 of 12.
What analysts expect from DHC
5 analysts cover Diversified Healthcare; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $10.15, 33.7% above the latest close of $7.59. Analysts expect earnings of −$0.63 per share for 2026, +47.1% from a year earlier. For 2027 the average estimate is −$0.43 per share on revenue of $1.6 billion. Diversified Healthcare beat the EPS estimate in 8 of the last 12 quarters.
Related: DHC income statement, DHC key metrics, DHC chart. See the DHC stock overview for the latest quote and news.
DHC forecast FAQ
What is Diversified Healthcare's price target?
The average analyst price target for Diversified Healthcare is $10.15, 33.7% above the latest close of $7.59.
Is Diversified Healthcare a buy, hold or sell?
Of 5 analysts covering Diversified Healthcare, 2 rate it a strong buy, 1 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Diversified Healthcare's EPS forecast?
Analysts forecast −$0.63 per share for 2026 (range −$0.66 to −$0.59); for 2027 the estimate is −$0.43.
What is Diversified Healthcare's revenue forecast?
The average revenue estimate for 2026 is $1.5 billion, growth of −4.2%; for 2027 it is $1.6 billion.
When does Diversified Healthcare report earnings?
Diversified Healthcare is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes; the EPS estimate is $0.15.
Does Diversified Healthcare usually beat earnings estimates?
Diversified Healthcare reported EPS at or above the analyst estimate in 8 of the last 12 quarters.